The causes of Alzheimer’s disease have long puzzled researchers, especially when most older adults show signs of the illness ...

New findings from the FACEHBI study show that baseline amyloid PET scans in people with subjective cognitive decline can ...

A new study indicates that the drug suvorexant could reduce proteins associated with Alzheimer's by improving sleep quality.

In further support of that finding, the researchers determined—with the help of AI—that PHGDH plays a previously undiscovered ...

Panelists discuss how managing patients with mild cognitive impairment using amyloid-targeting therapies faces significant barriers including limited healthcare infrastructure for complex diagnostic ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

A team of scientists, including researchers from University College London (UCL), has discovered key differences in how four ...

Researchers have developed a tau-targeting vaccine that could help prevent the progression of Alzheimer’s disease by ...

Researchers hope to launch human clinical trials in their quest for a vaccine to prevent the buildup of pathological tau after demonstrating that this vaccine generated a robust immune response in ...

A team of scientists including UCL researchers has tested four anti-amyloid Alzheimer's therapeutics to find out how the drugs bind to toxic amyloid beta protein to tackle the disease.

Researchers have developed engineered human microglia that detect disease-related brain changes and release therapeutic ...

A new way to deliver disease-fighting proteins throughout the brain may improve the treatment of Alzheimer's disease and other neurological disorders, according to University of California, Irvine ...